Search - tctmd.com

Displaying 361 - 380 of 585

Sort: Relevancy | Date

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

FAVOR II China: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Bo Xu

October 31, 2017

Presentation TCT 2017

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

Presenter: David P. Faxon, Joseph A. Hill, Ling Tao

October 31, 2017

Presentation TCT 2017

TCT 73: Off-Pump versus On-Pump Coronary Artery Bypass Surgery for Left Main Revascularization: Insights From the EXCEL Trial

Presenter: Adrian P. Banning, John D. Puskas, Umberto Benedetto, MD

October 31, 2017

Presentation TCT 2017

ABSORB II: 4-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Robert-Jan van Geuns, Bernard R. Chevalier

October 31, 2017

Presentation TCT 2017

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

Presenter: Hyo-Soo Kim, Quang Ngoc Nguyen, Stephane Noble

October 31, 2017

Presentation TCT 2017

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Stephen G. Ellis

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

Presentation TCT 2017

Debate: CT-FFR Will Replace Most Diagnostic Catheterizations!

Presenter: Pamela S. Douglas, Paul S. Teirstein, Jonathon A. Leipsic

October 30, 2017

Presentation TCT 2017

Debate: Invasive Angiography With Coronary Physiology and Intravascular Imaging Trumps Noninvasive Imaging!

Presenter: Pamela S. Douglas, Paul S. Teirstein, Justin E. Davies

October 30, 2017

Presentation TCT 2017

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Presenter: Robert A. Byrne, Ran Kornowski, Bernardo Cortese

October 30, 2017

Presentation TCT 2017

Evaluation of Suspected Coronary Artery Disease With Non-invasive and Invasive Imaging: What Do the US Guidelines and AUC Say?

Presenter: Pamela S. Douglas, Paul S. Teirstein, James K. Min

October 30, 2017

Presentation TCT 2017

Evaluation of Suspected Coronary Artery Disease With Noninvasive and Invasive Imaging: What Do the Data and EU Guidelines Say?

Presenter: Pamela S. Douglas, Paul S. Teirstein, Stephan Achenbach

October 30, 2017

Presentation TCT 2017

CABG Remains the Gold Standard for Left Main Coronary Artery Disease!

Presenter: Robert A. Guyton

October 30, 2017

Presentation TCT 2017

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Presenter: Anthony H. Gershlick

October 30, 2017

Presentation TCT 2017

Why Are Hypertension and Coronary Artery Disease So Connected?

Presenter: Mark C. Bates, Bernard J. Gersh, Suzanne Oparil

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Presentation TCT 2017

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Mitchell W. Krucoff

October 30, 2017

Presentation TCT 2017

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

Presenter: Fernando Alfonso, Roman Tarasov

October 30, 2017

Advertisement

Long-term Absorb BVS Data Continue to Disappoint

FAVOR II China: Diagnostic Accuracy of the Angiographic Quantitative Flow Ratio in Patients With Coronary Artery Disease

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

TCT 73: Off-Pump versus On-Pump Coronary Artery Bypass Surgery for Left Main Revascularization: Insights From the EXCEL Trial

ABSORB II: 4-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Switzerland Presents: A Case of Severe Symptomatic Aortic Stenosis and Complex Coronary Artery Disease - ECMO Support?

ABSORB IV: 30-Day Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Debate: CT-FFR Will Replace Most Diagnostic Catheterizations!

Debate: Invasive Angiography With Coronary Physiology and Intravascular Imaging Trumps Noninvasive Imaging!

Does DCB Technology Have an Important Role in Treatment of De Novo Coronary Artery Disease? If Not Today, Tomorrow?

Evaluation of Suspected Coronary Artery Disease With Non-invasive and Invasive Imaging: What Do the US Guidelines and AUC Say?

Evaluation of Suspected Coronary Artery Disease With Noninvasive and Invasive Imaging: What Do the Data and EU Guidelines Say?

CABG Remains the Gold Standard for Left Main Coronary Artery Disease!

PCI is Now the Preferred Option for Left Main Coronary Artery Disease!

Why Are Hypertension and Coronary Artery Disease So Connected?

Live From Denver: TCT 2017, Day One

HARMONEE: A Randomized Trial of a Bioabsorbable Polymer-Based DES With a Luminal CD34+ Antibody Coating vs a Durable Polymer-Based DES in Patients With Coronary Artery Disease

HREVS: A Randomized Trial of PCI vs CABG vs Hybrid Revascularization in Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content